The effect of low temperature plasma (LTP) on polyester (PET) is investigated by examining the changes in the dyeing properties of treated PET fabrics. An optimum condition for LTP treatment is determined by orthogonal analysis and this treatment condition was used through out the study. After LTP treatment, the PET fabric samples exhibit better hydrophilicity and the dyeability of the fabric is increased and such improvement is more pronounced in the case of high energy disperse dyes. Scanning electron microscope (SEM) observation also reveals that the surface of the treated PET fibre becomes rough with the formation of microtroughs.
The purpose of this study was to enhance the glass-transition temperature of poly(butylene 2,5-thiophenedicarboxylate) (PBTF). A series of poly(butylene-co-1,4-cyclohexanedimethylene 2,5-thiophenedicarboxylate)s (PBCTFs) were synthesized from 2,5-thiophenedicarboxylic acid, 1,4-cyclohexanedimethanol (CHDM), and 1,4-butanediol. CHDM can increase the chain rigidity and lead the β relaxation temperature shift to lower temperature. Consequently, PBCTFs showed not only the high glass-transition temperature, but also high elongations at break. PBTF was a crystalline polyester. However, differential scanning calorimetry and wide-angle Xray diffraction results suggested PBCTFs were amorphous polyesters. Thermogravimetric analysis results indicated the thermal stability of copolyesters was gradually enhanced with increasing the CHDM content. When the CHDM content was 95 mol %, PBCTF95 exhibited high glass-transition temperature (69.2 C), tensile strength (44.4 MPa), and elongation at break (205%).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.